Cumberland Pharmaceuticals (CPIX) Gross Profit (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Gross Profit across 17 years of filings, most recently posting $7.2 million for Q1 2026.

• In Q1 2026, Gross Profit fell 30.04% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $24.3 million (down 29.84% YoY), while the FY2025 annual figure was $37.9 million, up 21.01% from the prior year.
• Gross Profit came in at $7.2 million for Q1 2026 at Cumberland Pharmaceuticals, down from $11.4 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $11.4 million in Q4 2025 to a low of -$1.6 million in Q2 2025.
• Average Gross Profit over 5 years is $7.8 million, with a median of $8.1 million recorded in 2024.
• The largest YoY upside for Gross Profit was 48.61% in 2025 against a maximum downside of 120.04% in 2025.
• Over 5 years, Gross Profit stood at $6.5 million in 2022, then increased by 20.85% to $7.8 million in 2023, then gained by 8.13% to $8.5 million in 2024, then soared by 35.21% to $11.4 million in 2025, then sank by 37.07% to $7.2 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $7.2 million in Q1 2026, $11.4 million in Q4 2025, and $7.3 million in Q3 2025.